Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward

Overview of attention for article published in Neuropsychopharmacology, August 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 4 X users

reddit: 1 Redditor

Readers on

mendeley: 35 Mendeley

So far, Altmetric has seen 6 X posts from 4 X users, with an upper bound of 30,461 followers.

#ThisWeekInNPP Frye & Nemeroff respond to Sun & colleagues regarding "Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection" Previous responses here: https://t.co/D98b3aCVC…

#ThisWeekInNPP A response from Sun, Berenbrok, & Stevenson to Frye & Nemeroff's perspective piece - Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward Original article https://t.co/EDI6b96Ijs N…

RT @dawso007: Current evidence is weak but the authors discuss... Frye, M.A., Nemeroff, C.B. Pharmacogenomic testing for antidepressant tr…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.